NASDAQ
Lixte Biotechnology Holdings, Inc. (LIXT) has a current ratio of 3.88x as of Monday, May 25, 2026. This represents a 67.53% decrease compared to its 12-month average of 11.96x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.